A human papillomavirus type 16 vaccine by oral delivery of L1 protein

Virus Research

Volumn 110, Issue 1-2, 2005, Pages 81-90

  Sasagawa, Toshiyuki ^a   Tani, Mayuko ^a   Basha, Walid ^a   Rose, Robert C ^b   Tohda, Hideki ^c   Giga Hama, Yuko ^c   Azar, Khadijeh K ^a   Yasuda, Hideyo ^a   Sakai, Akemi ^a   Inoue, Masaki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c ASAHI GLASS CO LTD   (Japan)

Author keywords

Fission yeast; Iga; Igg; Mucosal immunity; Neutrolization

Indexed keywords

ADJUVANT; ANTIBODY; HUMAN PAPILLOMA VIRUS LIKE PARTICLE VACCINE; HUMAN PAPILLOMA VIRUS TYPE 16 PROTEIN L1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; TOXIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG TOLERANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZE DRYING; FUNGAL CELL; FUNGAL STRAIN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNIZATION; INTESTINE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; SCHIZOSACCHAROMYCES POMBE; VAGINA; VIRUS PARTICLE;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; SCHIZOSACCHAROMYCES POMBE;

EID: 20244382261     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2005.02.001     Document Type: Article

References (31)

1. C. Balmelli, R. Roden, A. Potts, J. Schiller, P. De Grandi, and D. Nardelli-Haefliger Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions J. Virol. 72 1998 8220 8229
2. K.S. Barone, M.R. Reilly, M.P. Flanagan, and J.G. Michael Abrogation of oral tolerance by feeding encapsulated antigen Cell. Immunol. 199 2000 65 72
3. S. Biemelt, U. Sonnewald, P. Galmbacher, L. Willmitzer, and M. Muller Production of human papillomavirus type 16 virus-like particles in transgenic plants J. Virol. 77 2003 9211 9220
4. E.L. Franco, L.L. Villa, J.P. Sobrinho, J.M. Prado, M.C. Rousseau, M. Desy, and T.E. Rohan Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer J. Infect. Dis. 180 1999 1415 1423
5. L.C. Freytag, and J.D. Clements Bacterial toxins as mucosal adjuvants Curr. Top. Microbiol. Immunol. 236 1999 215 236
6. S. Gerber, C. Lane, D.M. Brown, E. Lord, M. DiLorenzo, J.D. Clements, E. Rybicki, A.L. Williamson, and R.C. Rose Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA J. Virol. 75 2001 4752 4760
7. S.J. Goldie, D. Grima, M. Kohli, T.C. Wright, M. Weinstein, and E. Franco A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine Int. J. Cancer 106 2003 896 904
8. M.E. Hagensee, J.J. Carter, G.C. Wipf, and D.A. Galloway Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies Virology 206 1995 174 182
9. C.D. Harro, Y.Y. Pang, R.B. Roden, A. Hildesheim, Z. Wang, M.J. Reynolds, T.C. Mast, R. Robinson, B.R. Murphy, R.A. Karron, J. Dillner, J.T. Schiller, and D.R. Lowy Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine J. Natl. Cancer Inst. 93 2001 284 292
10. G.Y. Ho, R. Bierman, L. Beardsley, C.J. Chang, and R.D. Burk Natural history of cervicovaginal papillomavirus infection in young women N. Engl. J. Med. 338 1998 423 428
11. S.J. Kim, C. Lee, S.Y. Lee, I. Kim, J.S. Park, T. Sasagawa, J.J. Ko, S.E. Park, and Y.K. Oh Enhanced immunogenicity of human papillomavirus 16 L1 genetic vaccines fused to an ER-targeting secretory signal peptide and RANTES Gene Ther. 10 2003 1268 1273
12. R. Kirnbauer, J. Taub, H. Greenstone, R. Roden, M. Durst, L. Gissmann, D.R. Lowy, and J.T. Schiller Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles J. Virol. 67 1993 6929 6936
13. L.A. Koutsky, K.A. Ault, C.M. Wheeler, D.R. Brown, E. Barr, F.B. Alvarez, L.M. Chiacchierini, K.U. Jansen Proof of Principle Study Investigators A controlled trial of a human papillomavirus type 16 vaccine N. Engl. J. Med. 347 2002 1645 1651
14. S.L. Kulasingam, and E.R. Myers Potential health and economic impact of adding a human papillomavirus vaccine to screening programs JAMA 290 2003 781 789
15. M. Molano, A. Van den Brule, M. Plummer, E. Weiderpass, H. Posso, A. Arslan, C.J. Meijer, N. Munoz, S. Franceschi HPV Study Group Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based 5-year follow-up study Am. J. Epidemiol. 158 2003 486 494
16. N. Munoz, F.X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K.V. Shah, P.J. Snijders, C.J. Meijer International Agency for Research on Cancer Multicenter Cervical Cancer Study Group Epidemiologic classification of human papillomavirus types associated with cervical cancer N. Engl. J. Med. 348 2003 518 527
17. D. Nardelli-Haefliger, R. Roden, C. Balmelli, A. Potts, J. Schiller, and P. De Grandi Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice J. Virol. 73 1999 9609 9613
18. D.M. Parkin, F.I. Bray, and S.S. Devesa Cancer burden in the year 2000, 2001. The global picture Eur. J. Cancer 37 2001 54 66
19. P. Pushko, T. Sasagawa, J. Cuzik, and L. Crawford Sequence variation in the capsid protein genes of HPV16 J. Gen. Virol. 75 1994 911 916
20. R.C. Rose, W. Bonnez, R.C. Reichman, and R.L. Garcea Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles J. Virol. 67 1993 1936 1944
21. R.C. Rose, W. Bonnez, C. DaRin, D.J. McCance, and R.C. Reichman Serological differentiation of human papillomavirus types 11 16 and 18 using recombinant virus-like particles J. Gen. Virol. 75 1994 2445 2449
22. T. Sasagawa, P. Pushko, G. Steers, S.E. Gschmeissner, M.A. Hajibagheri, J. Finch, L. Crawford, and M. Tommasino Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe Virology 206 1995 126 135
23. T. Sasagawa, M. Inoue, M. Lehtinen, W. Zhang, S.E. Gschmeissner, M.A. Hajibagheri, J. Finch, and L. Crawford Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions Clin. Diagn. Lab. Immunol. 3 1996 403 410
24. T. Sasagawa, H. Yamazaki, Y.Z. Dong, S. Satake, M. Tateno, and M. Inoue Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions Int. J. Cancer 75 1998 529 535
25. T. Sasagawa, W. Basha, H. Yamazaki, and M. Inoue High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women Cancer Epidemiol. Biomark. Prev. 10 2001 45 52
26. Sasagawa, T., Tani, M., Yasuda, H., Azar, K.K., Fukae, T., Ukita, T., Yamazaki, H., Satake, S., Nakano, T., Inoue, M., in press. Sexual behavior and high-risk human papillomavirus (HPV) infections in Japanese women. Sex. Trans. Inf.
27. R.W. Tindle Immune evasion in human papillomavirus-associated cervical cancer Nat. Rev. Cancer 2 2002 59 65
28. H. Tohda, H. Okada, Y. Giga-Hama, H. Okayama, and H. Kumagai A copy-number-controlled expression vector for the fission yeast Schizosaccharomyces pombe Gene 150 1994 275 280
29. H. Warzecha, H.S. Mason, C. Lane, A. Tryggvesson, E. Rybicki, A.L. Williamson, J.D. Clements, and R.C. Rose Oral immunogenicity of human papillomavirus-like particles expressed in potato J. Virol. 77 2003 8702 8711
30. B.H. Yang, F.I. Bray, D.M. Parkin, J.W. Sellors, and Z.F. Zhang Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost Int. J. Cancer 109 2004 418 424
31. H. zur Hausen Human papillomaviruses in the pathogenesis of anogenital cancer Virology 184 1991 9 13